178 related articles for article (PubMed ID: 31505082)
1. The Clinical Relevance of Pain Severity Changes: Is There Any Difference Between Asian and Caucasian Patients With Osteoarthritis Pain?
Yue L; Wang J; Enomoto H; Fujikoshi S; Alev L; Cheng YY; Skljarevski V
Pain Pract; 2020 Feb; 20(2):129-137. PubMed ID: 31505082
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of duloxetine in Chinese patients with chronic pain due to osteoarthritis: a randomized, double-blind, placebo-controlled study.
Wang G; Bi L; Li X; Li Z; Zhao D; Chen J; He D; Wang CN; Dueñas H; Skljarevski V; Yue L
Osteoarthritis Cartilage; 2017 Jun; 25(6):832-838. PubMed ID: 28043937
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data.
Wang G; Bi L; Li X; Li Z; Zhao D; Chen J; He D; Wang CN; Wu T; Dueñas H; Skljarevski V; Yue L
BMC Musculoskelet Disord; 2019 Apr; 20(1):174. PubMed ID: 31010413
[TBL] [Abstract][Full Text] [Related]
5. The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders.
Farrar JT; Pritchett YL; Robinson M; Prakash A; Chappell A
J Pain; 2010 Feb; 11(2):109-18. PubMed ID: 19665938
[TBL] [Abstract][Full Text] [Related]
6. Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
Konno S; Oda N; Ochiai T; Alev L
Spine (Phila Pa 1976); 2016 Nov; 41(22):1709-1717. PubMed ID: 27831985
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients.
Murakami M; Osada K; Mizuno H; Ochiai T; Alev L; Nishioka K
Arthritis Res Ther; 2015 Aug; 17(1):224. PubMed ID: 26296539
[TBL] [Abstract][Full Text] [Related]
8. An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain.
Konno SI; Alev L; Oda N; Ochiai T; Enomoto H
Pain Med; 2019 Aug; 20(8):1479-1488. PubMed ID: 30856270
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of duloxetine in patients with chronic low back pain.
Skljarevski V; Desaiah D; Liu-Seifert H; Zhang Q; Chappell AS; Detke MJ; Iyengar S; Atkinson JH; Backonja M
Spine (Phila Pa 1976); 2010 Jun; 35(13):E578-85. PubMed ID: 20461028
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of duloxetine in Japanese patients with chronic knee pain due to osteoarthritis: an open-label, long-term, Phase III extension study.
Uchio Y; Enomoto H; Ishida M; Tsuji T; Ochiai T; Konno S
J Pain Res; 2018; 11():1391-1403. PubMed ID: 30104894
[TBL] [Abstract][Full Text] [Related]
11. Responsiveness of the Intermittent and Constant Osteoarthritis Pain (ICOAP) scale in a trial of duloxetine for treatment of osteoarthritis knee pain.
Risser RC; Hochberg MC; Gaynor PJ; D'Souza DN; Frakes EP
Osteoarthritis Cartilage; 2013 May; 21(5):691-4. PubMed ID: 23485934
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
Arnold LM; Zhang S; Pangallo BA
Clin J Pain; 2012; 28(9):775-81. PubMed ID: 22971669
[TBL] [Abstract][Full Text] [Related]
13. Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial.
Arnold LM; Clauw D; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
J Rheumatol; 2010 Dec; 37(12):2578-86. PubMed ID: 20843911
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of duloxetine by prior NSAID use in the treatment of chronic osteoarthritis knee pain: A post hoc subgroup analysis of a randomized, placebo-controlled, phase 3 study in Japan.
Enomoto H; Fujikoshi S; Tsuji T; Sasaki N; Tokuoka H; Uchio Y
J Orthop Sci; 2018 Nov; 23(6):1019-1026. PubMed ID: 30126675
[TBL] [Abstract][Full Text] [Related]
16. Onset of response with duloxetine treatment in patients with osteoarthritis knee pain and chronic low back pain: a post hoc analysis of placebo-controlled trials.
Williamson OD; Schroer M; Ruff DD; Ahl J; Margherita A; Sagman D; Wohlreich MM
Clin Ther; 2014 Apr; 36(4):544-51. PubMed ID: 24650448
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of duloxetine in patients with knee osteoarthritis or chronic low back pain with early pain reduction: An exploratory post-hoc analysis of Japanese phase 3, 1-year extension studies.
Itoh N; Uchio Y; Tsuji T; Ishida M; Ochiai T; Konno S
J Orthop Sci; 2022 May; 27(3):717-724. PubMed ID: 33958268
[TBL] [Abstract][Full Text] [Related]
18. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial.
Skljarevski V; Zhang S; Desaiah D; Alaka KJ; Palacios S; Miazgowski T; Patrick K
J Pain; 2010 Dec; 11(12):1282-90. PubMed ID: 20472510
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
[TBL] [Abstract][Full Text] [Related]
20. Estimation of minimum clinically important difference for pain in fibromyalgia.
Mease PJ; Spaeth M; Clauw DJ; Arnold LM; Bradley LA; Russell IJ; Kajdasz DK; Walker DJ; Chappell AS
Arthritis Care Res (Hoboken); 2011 Jun; 63(6):821-6. PubMed ID: 21312349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
